People · Operator
Named in public records as an officer, director or promoter · active 2009–2009 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| BioVex Group, Inc. | — | Biotechnology | Series B | $38.0M | $749.5M | 2009 |
Sander Sebastien Slootweg at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Sander Sebastien Slootweg on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Somu Subramaniam | 1 | 17 |
| Suzette Dutch | 1 | 3 |
| J. Sebastien Cleiftie | 1 | 2 |
| Jan Van Heek | 1 | 2 |
| Reenie P. McCarthy | 1 | 2 |
| Stephen Gorgol | 1 | 1 |
| Colin Love | 1 | 1 |
| Philippe Guinot | 1 | 1 |
| Sander Slootweg | 1 | 1 |
| Len Post | 1 | 1 |
| Steven Prelack | 1 | 1 |
| Robert Coffin | 1 | 1 |
| Somu Sebastien Subramaniam | 1 | 1 |
| Stephen Sebastien Reeders | 1 | 1 |
| Philip Astley-Sparke | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.